1. Home
  2. FNGR vs CASI Comparison

FNGR vs CASI Comparison

Compare FNGR & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNGR
  • CASI
  • Stock Information
  • Founded
  • FNGR 2016
  • CASI 1991
  • Country
  • FNGR Singapore
  • CASI China
  • Employees
  • FNGR N/A
  • CASI N/A
  • Industry
  • FNGR Computer Software: Prepackaged Software
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNGR Technology
  • CASI Health Care
  • Exchange
  • FNGR Nasdaq
  • CASI Nasdaq
  • Market Cap
  • FNGR 68.3M
  • CASI 58.8M
  • IPO Year
  • FNGR N/A
  • CASI 1996
  • Fundamental
  • Price
  • FNGR $1.18
  • CASI $2.62
  • Analyst Decision
  • FNGR
  • CASI Strong Buy
  • Analyst Count
  • FNGR 0
  • CASI 1
  • Target Price
  • FNGR N/A
  • CASI $6.00
  • AVG Volume (30 Days)
  • FNGR 535.3K
  • CASI 42.2K
  • Earning Date
  • FNGR 01-14-2025
  • CASI 11-15-2024
  • Dividend Yield
  • FNGR N/A
  • CASI N/A
  • EPS Growth
  • FNGR N/A
  • CASI N/A
  • EPS
  • FNGR N/A
  • CASI N/A
  • Revenue
  • FNGR $33,570,107.00
  • CASI $22,055,000.00
  • Revenue This Year
  • FNGR $260.03
  • CASI N/A
  • Revenue Next Year
  • FNGR N/A
  • CASI $134.79
  • P/E Ratio
  • FNGR N/A
  • CASI N/A
  • Revenue Growth
  • FNGR N/A
  • CASI N/A
  • 52 Week Low
  • FNGR $1.03
  • CASI $2.05
  • 52 Week High
  • FNGR $3.96
  • CASI $8.19
  • Technical
  • Relative Strength Index (RSI)
  • FNGR 35.93
  • CASI 38.56
  • Support Level
  • FNGR $1.10
  • CASI $2.44
  • Resistance Level
  • FNGR $1.27
  • CASI $2.76
  • Average True Range (ATR)
  • FNGR 0.09
  • CASI 0.29
  • MACD
  • FNGR 0.02
  • CASI 0.03
  • Stochastic Oscillator
  • FNGR 40.00
  • CASI 21.18

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: